000			01892 a2200505 4500
005			20250515092351.0
264		0	_c20080221
008			200802s 0 0 eng d
022			_a1532-6535
024	7		_a10.1038/sj.clpt.6100378 _2doi
040			_aNLM _beng _cNLM
100	1		_aSattiraju, S
245	0	0	_aK(ATP) channel pharmacogenomics: from bench to bedside. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cFeb 2008
300			_a354-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650	0	4	_aATP-Binding Cassette Transporters _xdrug effects
650	0	4	_aAnimals
650	0	4	_aAnti-Arrhythmia Agents _xpharmacology
650	0	4	_aArrhythmias, Cardiac _xdrug therapy
650	0	4	_aCongenital Hyperinsulinism _xdrug therapy
650	0	4	_aDiabetes Mellitus _xdrug therapy
650	0	4	_aDrug Design
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xpharmacology
650	0	4	_aInfant, Newborn
650	0	4	_aInfant, Newborn, Diseases _xdrug therapy
650	0	4	_aInsulin _xmetabolism
650	0	4	_aInsulin Secretion
650	0	4	_aInsulin-Secreting Cells _xdrug effects
650	0	4	_aKATP Channels _xdrug effects
650	0	4	_aPatient Selection
650	0	4	_aPharmacogenetics
650	0	4	_aPolymorphism, Genetic
650	0	4	_aPotassium Channel Blockers _xpharmacology
650	0	4	_aPotassium Channels _xdrug effects
650	0	4	_aPotassium Channels, Inwardly Rectifying _xdrug effects
650	0	4	_aReceptors, Drug _xdrug effects
650	0	4	_aSulfonylurea Receptors
700	1		_aReyes, S
700	1		_aKane, G C
700	1		_aTerzic, A
773	0		_tClinical pharmacology and therapeutics _gvol. 83 _gno. 2 _gp. 354-7
856	4	0	_uhttps://doi.org/10.1038/sj.clpt.6100378 _zAvailable from publisher's website
999			_c17476758 _d17476758